Sage Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sage Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2013 to Q3 2024.
  • Sage Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $14.2M, a 50.5% decline year-over-year.
  • Sage Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $58M, a 23.3% decline year-over-year.
  • Sage Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $73.4M, a 19.1% increase from 2022.
  • Sage Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $61.6M, a 41.1% decline from 2021.
  • Sage Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $105M, a 9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $58M $14.2M -$14.5M -50.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $72.5M $17.2M +$5.47M +46.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $67M $13.7M -$6.34M -31.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $73.4M $12.9M -$2.3M -15.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $75.7M $28.7M +$15.5M +118% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 $60.1M $11.7M -$2.94M -20.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $63.1M $20M +$1.49M +8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $61.6M $15.2M -$5.4M -26.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $67M $13.2M -$21.2M -61.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $88.2M $14.6M -$13M -47.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $101M $18.6M -$3.42M -15.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $105M $20.6M -$96K -0.46% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $105M $34.3M +$14.2M +70.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $90.5M $27.7M +$3.63M +15.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $86.9M $22M -$9.13M -29.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $96M $20.7M -$9.94M -32.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $106M $20.1M -$23.6M -54% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $129M $24M -$10.7M -30.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $140M $31.1M -$13M -29.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $153M $30.7M -$961K -3.04% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $154M $43.7M +$18.2M +71.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $136M $34.8M +$5.74M +19.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $130M $44.1M +$28.3M +179% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $102M $31.6M +$21.4M +209% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $80.6M $25.5M +$15.7M +162% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $64.8M $29M +$19.7M +210% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $45.1M $15.8M +$9.61M +155% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $35.5M $10.2M +$152K +1.51% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $35.4M $9.73M +$4.98M +105% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $30.4M $9.35M +$4.89M +109% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $25.5M $6.21M +$2.49M +67.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $23M $10.1M +$6.01M +147% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-19
Q3 2016 $17M $4.75M +$341K +7.74% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $16.7M $4.47M -$933K -17.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $17.6M $3.71M +$2.37M +175% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $15.2M $4.09M +$2.76M +208% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-22
Q3 2015 $12.5M $4.41M +$3.72M +539% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $8.76M $5.4M +$5.06M +1511% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $3.7M $1.35M +$1.19M +743% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $2.51M $1.33M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-24
Q3 2014 $690K +$670K Jul 3, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $335K +$327K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $160K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q3 2013 $20K* Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $8K* Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.